Delaware
|
11-2920559
|
|
(State of incorporation)
|
(I.R.S. Employer Identification No.)
|
8000 Regency Parkway, Suite 542, Cary, NC 27518
|
(Address of principal executive offices, including Zip Code)
|
(919) 380-5000
|
(
Registrant’s telephone number, including area code)
|
Securities registered pursuant to Section 12(b) of the Act:
|
NONE
|
|
Securities registered pursuant to Section 12(g) of the Act:
|
Common Stock, $.001 par value
|
Large accelerated filer | o | Accelerated filer | o |
Non - accelerated filer | o | Smaller reporting company | þ |
Item
Number
|
Page
Number
|
|
3
|
||
10
|
||
14
|
||
14
|
||
14
|
||
14
|
||
15
|
||
16
|
||
16
|
||
24
|
||
24
|
||
24
|
||
25
|
||
26
|
||
27
|
||
30
|
||
35
|
||
37
|
||
38
|
||
39
|
||
43
|
||
F-1
|
●
|
A Regional Bank -
A large U.S. regional bank selected Cicero XM software to provide intelligent unified desktop solutions for their customer service operations and throughout their enterprise. Leveraging existing applications, the new solutions captures desktop activities, automates processes, provides user guidance, and displays composite views of information to improve user productivity and the customer experience.
|
●
|
A Fortune 500 Bank
- Cicero EDGE was implemented at a Fortune 500 global bank for approximately 7,000 Financial Advisors (FA) who provide wealth management support to high value clients. Prior to implementing Cicero EDGE, the FA’s had limited access to client data and resources. They were not allowed access to corporate systems via laptops due to stringent security restrictions. The results of implementing Cicero EDGE have been striking. Every application and tool FA’s have on their office computers is available on their iPads. They now have access to proprietary research, client materials, account and contact data, analyst reports as well as their email accounts.
|
●
|
Business Process Outsourcers
- use our software solution in contact centers to provide real time integration among existing back-office systems, eliminate redundant data entry, shorten call times, provide real-time data access and enhance customer service and service levels.
|
●
|
A financial institution
- uses our software solution to provide real-time integration among market data, customer account information, existing back-office systems and other legacy applications, eliminate redundant data entry, provide real-time data access and processing, and enhance customer service and service levels.
|
●
|
An insurance company
- IT and Cicero professionals created a Cicero desktop solution which integrated computer telephony integration, key business systems and numerous secondary applications in use in the contact centers and elsewhere within the organization. Using Cicero, the contact center agents now use a central, integrated dashboard to navigate between applications, with key information (like customer and policy numbers) passed automatically between applications.
|
●
|
Product functionality and features;
|
●
|
Availability and quality of support services;
|
●
|
Ease of product implementation;
|
●
|
Price;
|
●
|
Product reputation; and
|
●
|
Our financial stability.
|
●
|
Portal software offers the ability to aggregate information at a single point, but not the ability to integrate transactions from a myriad of information systems on the desktop. Plumtree is a representative company in the market.
|
●
|
Middleware software provides integration of applications through messages and data exchange implemented typically in the middle tier of the application architecture. This approach requires modification of the application source code and substantial infrastructure investments and operational expense. Reuters, TIBCO and IBM MQSeries are competitors in the middleware market.
|
●
|
CRM software offers application tools that allow developers to build product specific interfaces and custom applications. This approach is not designed to be product neutral and is often dependent on deep integration with our technology. Siebel and Salesforce.com are representative products in the CRM software category.
|
●
|
Recently, there have been several companies that offer capabilities similar to our software in that these companies advertise that they integrate applications without modifying the underlying code for those applications. OpenSpan is one company who advertises that they can non-invasively integrate at the point of contact or on the desktop.
|
●
|
make a special suitability determination for purchasers of our shares;
|
●
|
receive the purchaser's written consent to the transaction prior to the purchase; and
|
●
|
deliver to a prospective purchaser of our stock, prior to the first transaction, a risk disclosure document relating to the penny stock market.
|
2012
|
2011
|
|||||||||||||||
Quarter
|
High
|
Low
|
High
|
Low
|
||||||||||||
First
|
$ | 0.19 | $ | 0.05 | $ | 0.08 | $ | 0.05 | ||||||||
Second
|
$ | 0.19 | $ | 0.14 | $ | 0.12 | $ | 0.06 | ||||||||
Third
|
$ | 0.15 | $ | 0.08 | $ | 0.10 | $ | 0.05 | ||||||||
Fourth
|
$ | 0.09 | $ | 0.04 | $ | 0.06 | $ | 0.03 |
Debt
|
Interest
|
Series B Dividends
|
Common Stock
|
|||||||||||||
Launny Steffens
|
$ | 3,000,000 | $ | -- | $ | 165,333 | 21,102,222 | |||||||||
SOAdesk, LLC
|
300,000 | -- | -- | 2,000,000 | ||||||||||||
Private Investors
|
243,502 | 26,372 | -- | 1,799,155 | ||||||||||||
Scott Lustgarten
|
-- | 3,107 | 25,833 | 192,934 | ||||||||||||
Ahab Partner L.P.
|
-- | -- | 32,292 | 215,278 | ||||||||||||
Don Peppers
|
-- | -- | 30,578 | 203,852 | ||||||||||||
Ahab International Ltd.
|
-- | -- | 10,764 | 71,759 | ||||||||||||
Mark Landis
|
-- | 3,534 | -- | 23,562 | ||||||||||||
$ | 3,543,502 | $ | 33,013 | $ | 264,800 | 25,608,762 |
Plan Category
|
Number of Securities to
be issued upon exercise of
outstanding options
|
Weighted-average
exercise price of
outstanding options
|
Number of securities
remaining available under
equity compensation plans
(excluding securities reflected
in the first column)
|
|||||||||
Equity compensation plans approved by stockholders
|
3,921,493 | $ | 0.36 | 594,857 | ||||||||
Equity compensation plans not approved by stockholders
|
-0- | -- | -0- |
Years Ended December 31,
|
||||||||
2012
|
2011
|
|||||||
Revenue:
|
||||||||
Software
|
67.7 | % | 20.8 | % | ||||
Maintenance
|
22.2 | % | 47.3 | % | ||||
Services
|
10.1 | % | 31.9 | % | ||||
Total
|
100.0 | % | 100.0 | % | ||||
Cost of revenue:
|
||||||||
Software
|
11.7 | % | 21.5 | % | ||||
Maintenance
|
2.4 | % | 3.5 | % | ||||
Services
|
16.3 | % | 32.7 | % | ||||
Total
|
30.4 | % | 57.7 | % | ||||
Gross margin
|
69.6 | % | 42.3 | % | ||||
Operating expenses:
|
||||||||
Sales and marketing
|
31.6 | % | 51.6 | % | ||||
Research and product development
|
24.6 | % | 36.4 | % | ||||
General and administrative
|
15.8 | % | 36.5 | % | ||||
Total
|
72.1 | % | 124.5 | % | ||||
Loss from operations
|
(2.5 | )% | (82.2 | )% | ||||
Other income/(expense), net
|
(0.6 | )% | (9.1 | )% | ||||
Net loss
|
(3.1 | )% | (91.3 | )% |
2012
|
2011
|
|||||||
United States
|
100 | % | 100 | % |
Name
|
Age
|
Position(s)
|
||
John L Steffens
|
71
|
Director and Chairman
|
||
John Broderick
|
63
|
Director and Chief Executive Officer/Chief Financial Officer
|
||
Antony Castagno
|
45
|
Director and Chief Technology Officer
|
||
Mark Landis
|
71
|
Director
|
||
Bruce W. Hasenyager
|
71
|
Director
|
||
Jay R. Kingley
|
52
|
Director
|
||
Charles B. Porciello
|
77
|
Director
|
||
Bruce D. Miller
|
62
|
Director
|
||
John W. Atherton
|
70
|
Director
|
||
Don Peppers
|
62
|
Director
|
●
|
Setting the total compensation of our Chief Executive Officer and evaluating his performance based on corporate goals and objectives;
|
●
|
Reviewing and approving the Chief Executives Officer’s decisions relevant to the total compensation of the Company’s other executive officer;
|
●
|
Making recommendations to the Board of Directors with respect to equity-based plans in order to allow us to attract and retain qualified personnel; and
|
●
|
Reviewing director compensation levels and practices, and recommending, from time to time, changes in such compensation levels and practices of the Board of Directors.
|
●
|
Base salary;
|
●
|
Non-equity incentive plan compensation;
|
●
|
Long-term incentive compensation; and
|
●
|
Other benefits
|
Name and
Principal
Position
|
Fiscal
Year
|
Salary
|
Stock
Awards
(1)
|
Non- Equity
Incentive
Plan
Compensation
(2)
|
All Other
Compensation
(3)
|
Total
|
||||||||||||||||
John P. Broderick
Chief Executive Officer Chief /Financial Officer, Corporate Secretary
|
2012
|
$ | 175,000 | 75,000 | $ | 25,000 | $ | 6,462 | $ | 281,462 | ||||||||||||
2011
|
$ | 175,000 | -- | $ | 25,000 | $ | 6,030 | $ | 206,030 | |||||||||||||
Antony Castagno
Chief Technology Officer
|
2012
|
$ | 150,000 | -- | -- | $ | 5,792 | $ | 155,792 | |||||||||||||
2011
|
$ | 150,000 | -- | -- | $ | 5,402 | $ | 155,402 |
(1)
|
In November 2012, the Company issued Mr. Broderick a restricted stock award in the amount of 1,500,000 shares which will vest to him upon termination or a change of control. The Company valued the restricted stock award at the fair market value on the date of the award and is amortizing the total expense of $75,000 over the assumed life of two years.
|
(2)
|
Non-equity incentive plan compensation includes a bonus for certain revenue transactions for named executive earned during fiscal year ended December 31, 2012 and 2011. The revenue transaction was the acceptance of the first contract greater than $300,000 for each fiscal year.
|
(3)
|
Other compensation includes the Company’s portion of major medical insurance premiums and long term disability premiums for named executives during fiscal year ended December 31, 2012 and 2011, respectively.
|
Option Awards
|
Stock Awards
|
||||||||||||||||||||
Name
|
Number of Securities Underlying Unexercised Options # Exercisable
(Vested)
|
Number of Securities Underlying Unexercised Unearned Options# Unexercisable
(Unvested)
|
Option Exercise price ($)
|
Option Expiration date
|
Number of Shares of Stock That Have Not Vested
|
Market Value of Shares of Stock That Have Not Vested
|
|||||||||||||||
John P. Broderick
|
4,950 | (1) | -- | $ | 26.00 |
04/24/2013
|
|||||||||||||||
5,000 | (2) | -- | $ | 31.00 |
02/18/2014
|
||||||||||||||||
549,360 | (3) | -- | $ | 0.51 |
08/17/2017
|
||||||||||||||||
75,000 | (4) | -- | $ | 0.09 |
08/20/2020
|
||||||||||||||||
549,630 | (5) | $ | 27,481 | ||||||||||||||||||
1,500,000 | (6) | $ | 75,000 | ||||||||||||||||||
Antony Castagno
|
75,000 | (4) | -- | $ | 0.09 |
08/20/2020
|
(1)
|
These options were granted on April 24, 2003. This stock option vested and became exercisable in three equal annual installments with the first installment vesting on April 24, 2003.
|
(2)
|
These options were granted on February 18, 2004. This stock option vested and became exercisable in three equal annual installments with the first installment vesting on February 18, 2004.
|
(3)
|
These options were granted on August 17, 2007. This stock option vests in three equal installments with the first installment vesting on August 17, 2007.
|
(4)
|
These options were granted on August 20, 2010. This stock option vests in three equal installments with the first installment vesting on August 20, 2010.
|
(5)
|
These are restricted stock granted on August 17, 2007. The shares will vest to him upon his resignation or termination or a change of control.
|
(6)
|
These are restricted stock granted on November 9, 2012. The shares will vest to him in the event of the termination, with or without cause, of his employment by the Company or his resignation from the Company with or without cause or in the event of a change of control.
|
Base Salary
|
Restricted Shares Award
|
Deferred Compensation
|
Total Compensation and Benefits
|
|||||||||||||
John P. Broderick
|
||||||||||||||||
Death
|
$ | -- | $ | 102,481 | $ | 7,292 | $ | 109,773 | ||||||||
Disability
|
-- | 102,481 | 7,292 | 109,773 | ||||||||||||
Involuntary termination without cause
|
175,000 | 102,481 | 7,292 | 284,773 | ||||||||||||
Change in Control
|
175,000 | 102,481 | 7,292 | 284,773 | ||||||||||||
Antony Castagno
|
||||||||||||||||
Death
|
$ | -- | $ | -- | $ | 6,250 | $ | 6,250 | ||||||||
Disability
|
-- | -- | 6,250 | 6,250 | ||||||||||||
Involuntary termination without cause
|
75,000 | -- | 6,250 | 81,250 | ||||||||||||
Change in Control
|
-- | -- | 6,250 | 6,250 |
Name of Beneficial Owner
|
No. of Common Shares
|
% of Class
|
No. of Series A1 Shares
|
% of Class
|
No. of Series B Shares
|
% of Class
|
% of Combined Classes
|
|||||||||||||||||||||
John L. Steffens (1)
|
35,518,814 | 40.2 | % | 14.832 | 1.0 | % | 6,400.00 | 61.5 | % | 44.2 | % (2) | |||||||||||||||||
Jonathan Gallen (3)
|
9,699,840 | 11.3 | % | -- | * | 1,667.00 | 16.0 | % | 13.0 | % (4) | ||||||||||||||||||
Mark and Carolyn P. Landis (5)
|
3,783,717 | 4.4 | % | 1,326.136 | 86.0 | % | -- | * | 5.9 | % (6) | ||||||||||||||||||
SOAdesk LLC
|
5,168,860 | 6.1 | % | -- | * | 5,357.71 | 34.0 | % | 11.6 | % (7) | ||||||||||||||||||
Bruce Miller
|
2,892,655 | 3.4 | % | -- | * | -- | * | 3.4 | % (8) | |||||||||||||||||||
Don Peppers
|
2,127,512 | 2.5 | % | -- | * | 1,333.33 | 12.8 | % | 3.9 | % (9) | ||||||||||||||||||
John P. Broderick
|
2,686,918 | 3.1 | % | -- | * | -- | * | 3.1 | % (10) | |||||||||||||||||||
John W. Atherton
|
166,784 | * | -- | * | -- | * | * | (11) | ||||||||||||||||||||
Bruce W. Hasenyager
|
50,652 | * | -- | * | -- | * | * | (12) | ||||||||||||||||||||
Charles Porciello
|
98,286 | * | -- | * | -- | * | * | (13) | ||||||||||||||||||||
Antony Castagno
|
75,000 | * | -- | * | -- | * | * | (14) | ||||||||||||||||||||
Jay R. Kingley
|
19,000 | * | -- | * | -- | * | * | (15) | ||||||||||||||||||||
Scott Lustgarten
|
1,643,934 | 1.9 | % | -- | * | 1,000.00 | 9.6 | % | 3.0 | (16) | ||||||||||||||||||
All current directors and executive officers as a group (10 persons)
|
47,393,338 | 51.6 | % | 1,340.968 | 87.0 | % | 7,733.33 | 74.4 | % | 55.9 | %(17) |
*
|
Represents less than one percent of the outstanding shares.
|
1.
|
The address of John L. Steffens is 65 East 55
th
Street, New York, N.Y. 10022.
|
2.
|
Includes 32,262,529 shares of common stock, 14,832 common shares issuable upon conversion of the Series A-1 Convertible Preferred Stock, 6,400,000 common shares issuable upon conversion of the Series B Convertible Preferred Stock, and 3,238,285 shares issuable upon the exercise of warrants and 18,000 shares subject to stock options. The exercise prices of the warrants are as follows: 188,285 at $0.18 per share, 1,450,000 at $0.20 per share and 1,600,000 at $0.25. The exercise price of the stock options is 8,000 at $0.51 per share and 10,000 at $0.09 per share.
|
3.
|
The address of Mr. Gallen is 299 Park Avenue New York, New York 10171.
|
4.
|
Ahab Partner, L.P. (“Partners”), Ahab International, Ltd. (“International”), Queequeg Partners, L.P. (“Queequeg”) and Queequeg, Ltd. (“Limited,” and collectively with Partners, International and Queequeg, the “Funds”) held in aggregate 9,283,173 shares of common stock, 1,667,000 common shares issuable upon conversion of the Series B Convertible Preferred Stock and warrants to acquire 416,667 shares of common stock. The exercise prices of the warrants are 416,667 at $0.25. Jonathan Gallen possesses the sole power to vote and the sole power to direct the disposition of all securities of the Company held by the Funds. In addition, Jonathan Gallen held the power to direct the disposition of 100,000 shares of common stock held in private investment account. Accordingly, for the purposes of Rule 13d-3 under the Securities Exchange Act of 1934, as amended, Mr. Gallen may be deemed to beneficially own 11,366,840 shares of common stock of the Company.
|
5.
|
The address of Mark and Carolyn P. Landis is 503 Lake Drive, Princeton, New Jersey 08540.
|
6.
|
Includes 3,771,717 shares of common stock, 1,326,136 common shares issuable upon conversion of the Series A-1 Convertible Preferred Stock and 12,000 shares subject to stock options.
The exercise price of the stock options is 5,000 at $0.51 per share and 7,000 at $0.09 per share.
|
7.
|
Includes 2,000,000 shares of common stock, 3,068,860 shares of common stock issuable upon conversion of one-half of the principal and accumulated interest of a $700,000 convertible promissory note and 5,357,713 common shares issuable upon the conversion of the Series B Convertible Preferred Stock issuable upon conversion of a convertible promissory note in the principal amount of $700,000 and accumulated interest of $104,000.
|
8.
|
Consists of 2,774,655 shares of common stock, 18,000 shares subject to stock options and warrants to acquire 100,000 shares of common stock. The exercise prices of the warrants are 100,000 at $0.20. The exercise price of the stock options is 8,000 at $0.51 per share and 10,000 at $0.09 per share.
Mr. Miller has sole or shared voting or dispositive power with respect to the securities held by Delphi Partners, Ltd., which holds 509,267 shares of common
.
|
9.
|
Includes 1,582,179 shares of common stock and 1,333,333 common shares issuable upon conversion of the Series B Convertible Preferred Stock, warrants to acquire 533,333 shares of common stock and 12,000 shares subject to stock options. The exercise prices of the warrants are 333,333 at $0.25 per share and 200,000 at $0.20 per share. The exercise price of stock options is 5,000 at $0.51 per share and 7,000 at $0.09 per share.
|
10.
|
Includes 3,248 shares of common stock. 634,310 shares subject to stock options exercisable within sixty (60) days and 2,049,360 shares of restricted stock that is awarded upon termination or change of control. The exercise prices of stock options range from $0.09 to $39 per share of common stock.
|
11.
|
Includes 148,784 shares of common stock, and 100 shares of common stock held in a self-directed IRA and 18,000 shares subject to stock options. The exercise price of stock options is 8,000 at $0.51 per share and 10,000 at $0.09 per share of common stock.
|
12.
|
Consists of 32,652 shares of common stock and 18,000 shares subject to stock options. The exercise prices of stock options are as follows: 1,000 at $35.00 per share, 8,000 at $0.51 per share and 10,000 at $0.09 per share of common stock.
|
13.
|
Consists of 80,286 shares of common stock and 18,000 shares subject to stock options. The exercise price of stock options is 8,000 at $0.51 per share and 10,000 at $0.09 per share of common stock.
|
14.
|
Consists of 75,000 shares subject to stock options. The exercise price of the stock options is $0.09 per share of common stock.
|
15.
|
Consists of 1,000 shares of common stock and 18,000
shares subject to stock options. The exercise prices of stock options are as follows: 1,000 at $34.00 per share, 8,000 at $0.51per share and 10,000 at $0.09 per share of common stock.
|
16.
|
Includes 1,634,934 shares of common stock and 1,000,000 common shares issuable upon conversion of the Series B Convertible Preferred Stock, warrants to acquire 450,000 shares of common stock. The exercise prices of the warrants are 200,000 at $0.20 per share and 250,000 at $0.25 per share.
|
17.
|
Includes shares issuable upon exercise of options and warrants exercisable within sixty (60) days as described in Notes 7-14 to our financial statements.
|
(A) | Financial Statements |
The following financial statements of the Company and the related reports of Independent Registered Public Accounting Firms thereon are set forth immediately following the Index of Financial Statements which appears on page F-1 of this report: |
Exhibit Number | Description | |
3.1 | Certificate of Incorporation of Level 8 Systems, Inc., a Delaware corporation, as amended and restated December 29, 2006 (incorporated by reference to exhibit 3.1 to Level 8’s Form 8-K filed January 17, 2007). | |
3.2 | Certificate of Designation relating to Series A1 Convertible Redeemable Preferred Stock (incorporated by reference to exhibit 3.2 to Level 8’s Form 8-K filed January 17, 2007). | |
3.3 | Certificate of Incorporation of Level 8 Systems, Inc., a Delaware corporation, as amended August 4, 2003 (incorporated by reference to exhibit 3.1 to Level 8’s Form 10-K filed March 31, 2004). | |
3.4 | Bylaws of Level 8 Systems, Inc., a Delaware corporation (incorporated by reference to exhibit 3.2 to Level 8’s Form 10-K filed April 2, 2002). | |
3.5 | Certificate of Designation relating to Series B Convertible Redeemable Preferred Stock (incorporated by reference to exhibit 3.1 to Level 8’s Form 8-K filed January 20, 2010). | |
4.1 | Form of Long term Promissory Note Stock Purchase Warrant (incorporated by reference to exhibit 4.19 to Cicero Inc.’s Form 10-K filed March 31, 2008). | |
4.2 | Form of Long term Promissory Note Stock Purchase Warrant (incorporated by reference to exhibit 4.17 to Cicero Inc.’s Form 10-K filed March 31, 2009). | |
4.3 | Form of Amended Long term Promissory Note Stock Purchase Warrant (incorporated by reference to exhibit 4.3 to Cicero Inc.’s Form 10-K filed March 31, 2011). | |
10.1 | Securities Purchase Agreement for Consortium IV (incorporated by reference to exhibit 10.1 to Cicero Inc.’s Form 10-K/A filed July 11, 2007). | |
10.2 | Amended PCA Shell License Agreement, dated as of January 3, 2002, between Level 8 Systems, Inc. and Merrill Lynch, Pierce, Fenner & Smith Incorporated (incorporated by reference to exhibit 10.2 to Level 8's Form 8-K, filed January 11, 2002). | |
10.3A | PCA Shell License Agreement between Level 8 Systems, Inc. and Merrill Lynch, Pierce, Fenner & Smith Incorporated (incorporated by reference to exhibit 10.2 to Level 8’s Report on Form 8-K, filed September 11, 2000). | |
10.3B | OEM License Agreement between Cicero Inc. and Merrill Lynch, Pierce, Fenner & Smith Incorporated (incorporated by reference to exhibit 10.12A to Cicero Inc.’s Form 10-K filed March 31, 2008). | |
10.3C | Software Support and Maintenance Schedule between Cicero Inc. and Merrill Lynch, Pierce, Fenner & Smith Incorporated (incorporated by reference to exhibit 10.12A to Cicero Inc.’s Form 10-K filed March 31, 2008). | |
10.4 | Employment Agreement between John P. Broderick and the Company effective January 1, 2011 (incorporated by reference to exhibit 10.16 to Cicero Inc.’s Form 10-K filed April 1, 2010). * | |
10.5 | Lease Agreement for Cary, N.C. offices, dated November 7, 2003, between Level 8 Systems, Inc. and Regency Park Corporation (incorporated by reference to exhibit 10.17 to Level 8’s Form 10-K, filed March 31, 2004). | |
10.6 | Level 8 Systems Inc. 1997 Stock Option Plan, as Amended and Restated (incorporated by reference to exhibit 10.2 to Level 8’s Registration Statement on Form S-1/A, filed September 22, 2000, File No. 333-44588).* | |
10.7A | Fifth Amendment to Level 8 Systems Inc. 1997 Stock Option Plan (incorporated by reference to exhibit 10.9A to Level 8’s Form 10-K filed April 2, 2002).* |
10.8B | Seventh Amendment to Level 8 Systems Inc. 1997 Stock Option Plan (incorporated by reference to exhibit 10.14 B to Level 8’s Form 10-K, filed March 31, 2004).* | |
10.9 | Lease Agreement for Cary, N.C. offices, dated August 16 , 2007, between Cicero Inc. and Regency Park Corporation (incorporated by reference to exhibit 10.21 to Cicero Inc.’s Form 10-K filed March 31, 2008). | |
10.10 | Cicero Inc. 2007 Employee Stock Option Plan (incorporated by reference to exhibit 10.22 to Cicero Inc.’s Form 10-K filed March 31, 2008). | |
10.11 | Agreement and Promissory Note of Cicero Inc., dated October 30, 2007 among Cicero Inc. and BluePhoenix Solutions Ltd. (incorporated by reference to exhibit 10.23 to Cicero Inc.’s Form 10-K filed March 31, 2008). | |
10.12 | Promissory Note of Cicero Inc., dated October 29, 2007 among Cicero Inc. and John L. Steffens (incorporated by reference to exhibit 10.24 to Cicero Inc.’s Form 10-K filed March 31, 2008). | |
10.13 | Securities Purchase Agreement, dated as of February 26, 2007, by and among Cicero Inc. and the Purchasers in the February Private Placement (incorporated by reference to exhibit 10.25 to Cicero Inc.’s Form 10-K filed March 31, 2008). | |
10.14 | Securities Purchase Agreement, dated as of August 15, 2007, by and among Cicero Inc. and the Purchasers in the August Private Placement (incorporated by reference to exhibit 10.26 to Cicero Inc.’s Form 10-K filed March 31, 2008). | |
10.15 | Revolving Loan Agreement dated November 3, 2008 among Cicero Inc. and Barbara Sivan (incorporated by reference to exhibit 10.15 to Cicero Inc., Form 10-K filed March 31, 2009). | |
10.16 | Employment Agreement between John P. Broderick and the Company effective January 1, 2012 (incorporated by reference to exhibit 10.16 to Cicero Inc., Form 10-K filed April 16, 2012). | |
10.17 | Form of Long Term Promissory Note dated March 31, 2009 (incorporated by reference to exhibit 10.17 to Cicero Inc., Form 10-K filed March 31, 2009). | |
10.18 | Employment Agreement between Antony Castagno and the Company effective January 1, 2012 (incorporated by reference to exhibit 10.16 to Cicero Inc., Form 10-K filed April 16, 2012).* | |
10.19
|
Asset Purchase Agreement dated January 15, 2010 between Cicero Inc., Vertical Thought Inc., and SOAdesk LLC (incorporated by reference to exhibit 2.1 to Cicero’s Form 8-K filed January 20, 2010). | |
10.20 | Amendment No. 1 to the Purchase Agreement dated January 15, 2010 between Cicero Inc., Vertical Thought Inc., and SOADesk LLC (incorporated by reference to exhibit 2.1 to Cicero’s Form 8-K/A filed April 2, 2010). | |
10.21 | Registration Rights Agreement, dated as of January 15, 2010, by and among Cicero Inc. and the Purchasers thereto (incorporated by reference to exhibit 4.4 to Cicero Inc.’s Form 8-K filed January 20, 2010) | |
10.23 | Source Code License Agreement between Cicero Inc. and Convergys Customer Management Group Inc. (incorporated by reference to exhibit 10.16 to Cicero Inc., Form 10-K filed April 16, 2012). | |
10.9
|
Lease Agreement for Cary, N.C. offices, dated July 21, 2010, between Cicero Inc. and Regency Park Corporation (incorporated by reference to exhibit 10.9 to Cicero Inc.’s Form 10-K filed March 31, 2011). | |
10.24 | Form of Short Term Promissory Note of Cicero Inc. among Cicero Inc. and John L. Steffens (incorporated by reference to exhibit 10.16 to Cicero Inc., Form 10-K filed April 16, 2012). | |
10.26 | Amended Employment Agreement between John P. Broderick and the Company effective January 1, 2012 (filed herewith) |
14.1 | Code of Ethics (incorporated by reference to exhibit 14.1 to Level 8’s Form 10-K/A, filed March 31, 2004). | |
21.1 | List of subsidiaries of the Company (filed herewith). | |
23.1 | Consent of Cherry Bekaert LLP (filed herewith). | |
23.2 | Consent of Marcum LLP (filed herewith). | |
31.1 | Certification of Chief Executive pursuant to Rule 13a-14(a) (filed herewith). | |
31.2 | Certification of Chief Financial Officer pursuant to Rule 13a-14(a) (filed herewith). | |
32.1 | Certification of John P. Broderick pursuant to 18 USC § 1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002 (filed herewith). |
CICERO INC. | |||
Date: April 15, 2013
|
By:
|
/s/ John P. Broderick | |
John P. Broderick | |||
Chief Executive Officer and Chief Financial Officer |
Signature
|
Title
|
Date
|
||
/
s/ John L. Steffens
|
Chairman of the Board
|
April 15, 2013
|
||
John L. Steffens
|
||||
/s/ John P. Broderick
|
Chief Executive Officer/Chief Financial Officer
|
April 15, 2013
|
||
John P. Broderick | (Principal Executive and Financial Officer) | |||
/s/ Antony Castagno
|
Chief Technology Officer
|
April 15, 2013
|
||
Antony Castagno | ||||
/s/ Mark Landis
|
Director
|
April 15, 2013
|
||
Mark Landis | ||||
/s/ Bruce Hasenyager
|
Director
|
April 15, 2013
|
||
Bruce Hasenyager | ||||
/s/ Jay Kingley
|
Director
|
April 15, 2013
|
||
Jay Kingley | ||||
/s/ Bruce D. Miller
|
Director
|
April 15, 2013
|
||
Bruce D. Miller | ||||
/s/ Charles Porciello
|
Director
|
April 15, 2013
|
||
Charles Porciello | ||||
/s/ John W. Atherton
|
Director
|
April 15, 2013
|
||
John W. Atherton | ||||
/s/ Don Peppers
|
Director
|
April 15, 2013
|
||
Don Peppers |
F-2 | ||||
F-3 | ||||
Financial Statements:
|
||||
F-4 | ||||
F-5 | ||||
F-6 | ||||
F-7 | ||||
F-9 |
December 31,
2012
|
December 31,
2011
|
|||||||
ASSETS
|
||||||||
Current assets:
|
||||||||
Cash
|
$ | 69 | $ | 184 | ||||
Trade accounts receivable, net
|
1,247 | 861 | ||||||
Prepaid expenses and other current assets
|
289 | 404 | ||||||
Total current assets
|
1,605 | 1,449 | ||||||
Property and equipment, net
|
47 | 32 | ||||||
Intangible asset, net (Note 6)
|
28 | 729 | ||||||
Goodwill (Note 6)
|
2,832 | 2,832 | ||||||
Total assets
|
$ | 4,512 | $ | 5,042 | ||||
LIABILITIES AND STOCKHOLDERS' DEFICIT
|
||||||||
Current liabilities:
|
||||||||
Short-term debt (Note 7)
|
$ | 826 | $ | 6,137 | ||||
Accounts payable
|
2,887 | 3,170 | ||||||
Accrued expenses:
|
||||||||
Salaries, wages, and related items
|
1,119 | 1,407 | ||||||
Other
|
271 | 424 | ||||||
Deferred revenue (Note 2)
|
1,389 | 1,611 | ||||||
Total current liabilities
|
6,492 | 12,749 | ||||||
Long-term debt (Note 8)
|
3,509 | 1,916 | ||||||
Total liabilities
|
10,001 | 14,665 | ||||||
Commitments and contingencies (Notes 15 and 16)
|
||||||||
Stockholders' deficit:
|
||||||||
Convertible preferred stock, $0.001 par value, 10,000,000 shares authorized
Series A-1 – 1,541.6 shares issued and outstanding at December 31, 2012 and 1,542.6 shares issued and outstanding at December 31, 2011, $500 per share liquidation preference (aggregate liquidation value of $771)
|
-- | -- | ||||||
Series B – 10,400 shares issued and outstanding at December 31, 2012 and 2011, $500 per share liquidation preference (aggregate liquidation value of $5,200)
|
-- | -- | ||||||
Common stock, $0.001 par value, 215,000,000 shares authorized at December 31, 2012 and 2011, respectively; 73,094,286 issued and outstanding at December 31, 2012 and 47,444,524 issued and outstanding at December 31, 2011 (Note 11)
|
73 | 47 | ||||||
Common stock - subscribed
|
10 | -- | ||||||
Additional paid-in-capital
|
236,919 | 232,506 | ||||||
Accumulated deficit
|
(242,491 | ) | (242,176 | ) | ||||
Total stockholders' deficit
|
(5,489 | ) | (9,623 | ) | ||||
Total liabilities and stockholders' deficit
|
$ | 4,512 | $ | 5,042 |
Years Ended December 31,
|
||||||||
2012
|
2011
|
|||||||
Revenue:
|
||||||||
Software
|
$ | 4,061 | $ | 676 | ||||
Maintenance
|
1,333 | 1,540 | ||||||
Services
|
603 | 1,038 | ||||||
Total operating revenue
|
5,997 | 3,254 | ||||||
Cost of revenue:
|
||||||||
Software
|
701 | 701 | ||||||
Maintenance
|
145 | 114 | ||||||
Services
|
979 | 1,062 | ||||||
Total cost of revenue
|
1,825 | 1,877 | ||||||
Gross margin
|
4,172 | 1,377 | ||||||
Operating expenses:
|
||||||||
Sales and marketing
|
1,897 | 1,679 | ||||||
Research and product development
|
1,476 | 1,183 | ||||||
General and administrative
|
949 | 1,189 | ||||||
Total operating expenses
|
4,322 | 4,051 | ||||||
Loss from operations before other income (charges)
|
(150 | ) | (2,674 | ) | ||||
Other income (charges):
|
||||||||
Interest expense
|
(547 | ) | (813 | ) | ||||
Other (Note 1)
|
509 | 517 | ||||||
(38 | ) | (296 | ) | |||||
Net loss
|
(188 | ) | (2,970 | ) | ||||
Deemed dividend on preferred stock and
8% preferred stock Series B dividend
|
127 | 126 | ||||||
Net loss applicable to common stockholders
|
$ | (315 | ) | $ | (3,096 | ) | ||
Loss per share – basic and diluted
|
$ | (0.00 | ) | $ | (0.07 | ) | ||
Average shares outstanding – basic and diluted
|
67,038 | 47,341 |
Common Stock
|
Preferred Stock
|
Additional
Paid-in
|
Accumulated
|
|||||||||||||||||||||||||
Shares | Amount | Shares |
Amount
|
Capital
|
(Deficit)
|
Total
|
||||||||||||||||||||||
Balance at December 31, 2010
|
47,098 | $ | 47 | 12 | -- | $ | 232,369 | $ | (239,080 | ) | $ | (6,664 | ) | |||||||||||||||
Dividend for preferred B stock
|
(126 | ) | (126 | ) | ||||||||||||||||||||||||
Beneficial conversion of preferred A stock
|
1 | -- | ||||||||||||||||||||||||||
Issuance of stock for payment of interest
|
345 | 26 | 26 | |||||||||||||||||||||||||
Options issued as compensation
|
75 | 75 | ||||||||||||||||||||||||||
Restricted shares issued as compensation
|
36 | 36 | ||||||||||||||||||||||||||
Net loss
|
(2,970 | ) | (2,970 | ) | ||||||||||||||||||||||||
Balance at December 31, 2011
|
47,444 | $ | 47 | 12 | -- | $ | 232,506 | $ | (242,176 | ) | $ | (9,623 | ) | |||||||||||||||
Dividend for preferred B stock
|
(127 | ) | (127 | ) | ||||||||||||||||||||||||
Beneficial conversion of preferred A stock
|
1 | -- | ||||||||||||||||||||||||||
Issuance of stock for payment of debt/interest
|
23,884 | 24 | 3,560 | 3,584 | ||||||||||||||||||||||||
Issuance of stock for payment of accrued dividends
|
1,765 | 2 | 263 | 265 | ||||||||||||||||||||||||
Common Stock – Subscription
|
10,200 | 10 | 500 | 510 | ||||||||||||||||||||||||
Options issued as compensation
|
48 | 48 | ||||||||||||||||||||||||||
Restricted shares issued as compensation
|
42 | 42 | ||||||||||||||||||||||||||
Net loss
|
(188 | ) | (188 | ) | ||||||||||||||||||||||||
Balance at December 31, 2012
|
83,294 | $ | 83 | 12 | -- | $ | 236,919 | $ | (242,491 | ) | $ | (5,489 | ) |
Years Ended December 31,
|
||||||||
2012
|
2011
|
|||||||
Cash flows from operating activities:
|
||||||||
Net loss
|
$ | (188 | ) | $ | (2,970 | ) | ||
Adjustments to reconcile net loss to net cash (used in) operating activities:
|
||||||||
Depreciation and amortization
|
725 | 722 | ||||||
Stock compensation expense
|
90 | 111 | ||||||
Bad debt expense
|
18 | 14 | ||||||
Gain on reversal of earn out contingency
|
-- | (517 | ) | |||||
Gain on forgiveness of debt
|
(598 | ) | -- | |||||
Gain on write down of accrued liability
|
(390 | ) | -- | |||||
Changes in assets and liabilities:
|
||||||||
Trade accounts receivable and related party receivables
|
(404 | ) | (738 | ) | ||||
Prepaid expenses and other assets
|
123 | (125 | ) | |||||
Accounts payable and accrued expenses
|
354 | 1,063 | ||||||
Deferred revenue
|
(222 | ) | 1,237 | |||||
Net cash used in operating activities
|
(492 | ) | (1,203 | ) | ||||
Cash flows from investing activities:
|
||||||||
Purchases of property and equipment
|
(39 | ) | (13 | ) | ||||
Cash paid for acquisition of SOAdesk assets
|
-- | -- | ||||||
Net cash used in investing activities
|
(39 | ) | (13 | ) | ||||
Cash flows from financing activities:
|
||||||||
Common stock subscription
|
187 | -- | ||||||
Borrowings under short and long-term debt
|
1,998 | 2,021 | ||||||
Repayments of short and long-term debt
|
(1,769 | ) | (664 | ) | ||||
Net cash provided by financing activities
|
416 | 1,357 | ||||||
Net (decrease)/increase in cash
|
(115 | ) | 141 | |||||
Cash at beginning of year
|
184 | 43 | ||||||
Cash at end of year
|
$ | 69 | $ | 184 | ||||
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
|
||||||||
Cash paid during the year for:
|
||||||||
Income taxes
|
$ | 15 | $ | 21 | ||||
Interest
|
$ | 263 | $ | 225 |
December 31,
|
||||||||
2012
|
2011
|
|||||||
Fair Value
|
$ | 3,420,397 | $ | 1,887,709 | ||||
Carrying Value
|
$ | 3,509,000 | $ | 1,916,000 |
2012
|
2011
|
|||||||
Stock options
|
3,921,493 | 4,296,193 | ||||||
Warrants
|
5,928,285 | 3,888,285 | ||||||
Preferred stock
|
11,941,618 | 11,942,618 | ||||||
21,791,396 | 20,127,096 |
2012
|
2011
|
|||||||
Fair value of common stock
|
$ | 0.14 | $ | 0.07 | ||||
Expected life (in years)
|
9.85 years
|
10.0 years
|
||||||
Expected volatility
|
186 | % | 140 | % | ||||
Risk free interest rate
|
0.19 | % | 0.12 | % | ||||
Expected dividend yield
|
0 | % | 0 | % |
Consideration:
|
||||
Cash paid
|
$ | 300,000 | ||
Convertible notes payable
|
2,225,000 | |||
Earn-out contingency
|
2,410,000 | |||
Total Consideration
|
$ | 4,935,000 | ||
Allocated to:
|
||||
Software
|
$ | 2,103,000 | ||
Goodwill ($141,000 is expected to be deductible for tax purposes)
|
$ | 2,832,000 | ||
$ | 4,935,000 |
2012
|
2011
|
|||||||
Current trade accounts receivable
|
$ | 1,247 | $ | 861 |
2012
|
2011
|
|||||||
Computer equipment
|
$ | 134 | $ | 322 | ||||
Furniture and fixtures
|
24 | 24 | ||||||
Office equipment
|
35 | 169 | ||||||
193 | 515 | |||||||
Less: accumulated depreciation and amortization
|
(146 | ) | (483 | ) | ||||
$ | 47 | $ | 32 |
2012
|
2011
|
|||||||
Term loan (a)
|
$ | -- | $ | 753 | ||||
Note payable asset purchase agreement (b)
|
-- | 1,121 | ||||||
Note payable related parties (c)
|
3 | 2,959 | ||||||
Notes payable (d)
|
823 | 1,304 | ||||||
$ | 826 | $ | 6,137 |
(a)
|
In October 2007, the Company agreed to restructure the note payable to Bank Hapoalim and guaranty by BluePhoenix Solutions. Under a new agreement with BluePhoenix, the Company made a principal reduction payment to Bank Hapoalim in the amount of $300,000. Simultaneously, BluePhoenix paid $1,671,000 to Bank Hapoalim, thereby discharging that indebtedness. The Company and BluePhoenix entered into a new note in the amount of $1,021,000, bearing interest at LIBOR plus 1.0% and maturing on December 31, 2011. In addition, BluePhoenix acquired 2,546,149 shares of the Company’s common stock in exchange for $650,000 paid to Bank Hapoalim to retire that indebtedness. Of the new note payable to BluePhoenix, approximately $350,000 was due on January 31, 2009 and the balance was due on December 31, 2011. During 2008, the Company paid $200,000 against the principal and BluePhoenix converted $50,000 of principal into 195,848 shares of Cicero common stock. In January 2009, the Company paid $100,000 against the principal. In January 2012, the Company entered into an addendum to the original note to extend the maturity of all outstanding principal and interest of $752,594 to December 31, 2012. At the time of the extension, the Company paid $150,000 towards principal and interest on this note. The unpaid principal and accumulated interest shall bear interest at a rate of LIBOR (3 months LIBOR, 0.581%) plus 6.7% per annum calculated quarterly. In March 2012, the Company made a $50,000 principal reduction payment. In April 2012, the Company paid off the note at a discount in the amount of $380,000 and recognized approximately $170,000 as a gain.
|
(b)
|
At December 31, 2011, the Company was indebted to SOAdesk LLC for the remaining portion of the related long term debt of $1,121,000. (See Note 8)
As part of the Asset Purchase Agreement, the Company was to pay to the shareholders of SOAdesk the sum of $525,000 on March 31, 2010. In March 2010, the terms of the Asset Purchase Agreement were amended and the Company issued a $525,000 convertible promissory note to SOAdesk in lieu of the $525,000 payment originally due on March 31, 2010. This note, which carried an annual interest rate of 5%, was secured by shares of the Company’s Series B Preferred Stock. The note was to mature on June 30, 2010 but was subsequently amended to extend the maturity date to September 30, 2010. As of September 30, 2010, the maturity date was further extended to March 31, 2011. In March 2011, the Company and SOAdesk agreed to extend the maturity on the note until March 31, 2012. In March 2012, the Company and SOAdesk agreed to extend the maturity on the note until December 31, 2012. In April 2010 and May 2011, the Company paid $100,000 and $4,000, respectively, against the principal. In April 2012, the note was paid in full.
|
(c)
|
From 2010 through 2012, the Company entered into several short term notes payable with John L. (Launny) Steffens, the Chairman of the Board of Directors, for various working capital needs. The notes bear interest at 12% per year and are unsecured. At December 31, 2011, the Company was indebted to Mr. Steffens in the amount of $3,065,000. In March 2012, Mr. Steffens converted $3,000,000 of his debt, which included $350,000 which was lent to the Company in the first quarter of 2012, into 20,000,000 shares of common stock of the Company at a price of $0.15 per share. In March 2012, Mr. Steffens agreed to refinance $465,000 of debt, of which only $115,000 was outstanding as of December 31, 2011, and $417,000 of accrued interest at an interest rate of 12% and a maturity date of March 31, 2013. As such this amount has been reclassified to long term debt as of December 31, 2011 (See Note 8). At December 31, 2012, the Company was indebted to Mr. Steffens in the approximate amount of $1,773,000 of principal and $168,000 in interest. In March 2013, Mr. Steffens agreed to extend the maturity date of all outstanding short term notes till April 1, 2014. As such this amount has been reclassified to long-term debt as of December 31, 2012. (See Note 8)
During 2012, the Company entered into short term notes payable with John Broderick, the Chief Executive Office and Chief Financial Officer, for various working capital needs. The notes bear interest at 12% and was unsecured. At December 31, 2012, the Company was indebted to Mr. Broderick in the approximate amount of $3,000. No interest was paid in fiscal 2012.
From time to time the Company entered into promissory notes with one of the Company’s former directors and the former Chief Information Officer, Anthony Pizi. The notes bear interest at 12% per annum. As of December 31, 2011, the Company was indebted to Anthony Pizi in the amount of $9,000. In March 2012, Mr. Pizi converted his indebtedness into 171,487 shares of common stock of the Company at a price of $0.15 per share.
|
(d)
|
The Company has issued a series of short term promissory notes with private lenders, which provide for short term borrowings, both secured by accounts receivable and unsecured. The notes in the amount of $407,000 and $718,000, respectively, as of December 31, 2012, and 2011 bear interest between 10% and 36% per annum. In March 2012, the Company converted $235,000 of these notes into 1,566,667 shares of Company’s common stock. In March 2012, certain private lenders agreed to refinance $83,000 of debt and $301,000 of accrued interest at an interest rate of 12% and a maturity date of March 31, 2013. As such this amount has been reclassified to long-term debt at December 31, 2011. (See Note 8) In March 2013, the same private lenders agreed to extend the maturity date to April 4, 2014. As such this amount has been classified as long term debt as of December 31, 2012. (See Note 8).
In July 2012, the Company entered into a restructuring settlement with a private lender whereby the lender agreed to accept $495,000 in full satisfaction of all principal and interest due under the Note agreements, as of June 1, 2012, plus interest in the amount of approximately $21,000 for the period from June 1, 2012 to July 31, 2012. In addition, the Company agreed to pay interest for the period after July 31, 2012 in the aggregate amount of approximately $67,000. This interest is to be paid in seven monthly installments of approximately $9,750 each from August 2012 through February 2013. The final payment of the remaining principal of approximately $416,000 was paid in February 2013.
|
At December 31, 2011, the Company was indebted for the remaining portion of the related long-term debt for several secured Promissory Notes with certain investors in the aggregate amount of $650,000 that were secured by the amount due under the Company’s support contract with Merrill Lynch (See Note 8) In March 2012, these notes were paid in full.
In August 2011, the Company entered into a promissory note with an employee for various working capital needs. The note bears interest at 6% per year and is unsecured. As of December 31, 2011, the Company was indebted to this employee in the amount of $19,000. In April 2012, this loan was paid in full.
|
2012
|
2011
|
|||||||
Note payable asset purchase agreement (a)
|
$ | 700 | $ | -- | ||||
Note payable – related party (b)
|
1,773 | 532 | ||||||
Other long-term debt (c)
|
1,036 | 1,384 | ||||||
$ | 3,509 | $ | 1,916 |
(a)
|
In January 2010, per the Asset Purchase Agreement, the Company entered into an unsecured convertible promissory note with SOAdesk for $700,000 with an annual interest rate of 5%. The note was originally scheduled to mature on March 31, 2010 but was subsequently amended to extend the maturity date to September 30, 2010 and was secured with shares of the Company’s Series B Preferred Stock. As of September 30, 2010, the maturity date was extended to March 31, 2011. Through a series of amendments, the maturity date was extended to December 31, 2012. In January 2013, the Company and SOAdesk LLC agreed to extend the maturity on the note to April 1, 2014 and as such the Company has reclassed the debt to long term. At December 31, 2012, the Company was indebted to SOAdesk in the amount of $700,000 in principal and $104,000 in interest.
The note is convertible into shares of Series B Convertible Preferred Stock at the rate of one share per every $150 of principal and interest due under the note. The Company is obligated to repay any principal of the loan with fifty percent of any gross proceeds of any Series B Preferred capital raise through maturity of the note. The note is convertible at the holder’s option at any time or at maturity.
|
(b)
|
From time to time during 2010 and 2011, the Company entered into several short term notes payable with John L. (Launny) Steffens, the Chairman of the Board of Directors, for various working capital needs. The notes bear interest at 12% per year and are unsecured. At December 31, 2011, the Company was indebted to Mr. Steffens in the amount of $3,065,000. In March 2012, Mr. Steffens converted $3,000,000 of his debt, which included $50,000 which was lent to the Company in the first quarter of 2012, into 20,000,000 shares of common stock of the Company at a price of $0.15 per share. In March 2012, Mr. Steffens agreed to refinance $465,000 of debt, of which only $115,000 was outstanding as of December 31, 2011,
and $417,000 of accrued interest at an interest rate of 12% and a maturity date of March 31, 2013, (See Note 7). As such this amount has been reclassified to long-term debt as of December 31, 2011. In December 2012, Mr. Steffens converted $300,000 of his debt into a subscription of 6,000,000 shares of the Company’s common stock at a price of $0.05 per share as part of a private investment in the Company’s stock. At December 31, 2012, the Company was indebted to Mr. Steffens in the approximate amount of $1,773,000 of principal and $168,000 in interest. In March 2013, Mr. Steffens agreed to extend the maturity date of all outstanding short term notes till April 1, 2014. As such this amount has been reclassified to long term debt as of December 31, 2012.
|
(c)
|
In January 2010, as part of the Asset Purchase Agreement, the Company entered into an unsecured Convertible Promissory Note with SOAdesk in the amount of $1,000,000. The note bears interest at 5% and is due November 14, 2015. The note is only convertible into shares of the Company’s common stock at the rate of one share for every $0.15 of principal and interest due under the note. The note is convertible at the option of the holder with one-third convertible in January 2011, two-thirds convertible in January 2012, and the entire note convertible in January 2013 or at maturity. In March 2012, SOAdesk elected to convert $300,000 of the outstanding note balance into 2,000,000 shares of Company’s Common Stock. At December 31, 2012 the Company was indebted to SOAdesk in the amount of $700,000.
|
In March 2012, certain private lenders agreed to refinance $83,000 of debt and $301,000 of accrued interest at an interest rate of 12% and a maturity date of March 31, 2013. As such this amount has been reclassified to long term debt at December 31, 2011. In March 2013, the maturity date of the note was extended to April 4, 2014. (See Note 7)
|
Year
|
||||
2014
|
$ | 2,809,000 | ||
2015
|
700,000 | |||
$ | 3,509,000 |
2012
|
2011
|
|||||||
Expected income tax benefit at statutory rate (34%)
|
$ | (64 | ) | $ | (1,010 | ) | ||
State taxes, net of federal tax benefit.
|
(10 | ) | (176 | ) | ||||
Effect of change in valuation allowance
|
(9,848 | ) | (15,568 | ) | ||||
Non-deductible expenses
|
6 | 12 | ||||||
Expiration of net operating loss deductions
|
9,916 | 16,742 | ||||||
Total
|
$ | -- | $ | -- |
2012
|
2011
|
|||||||
Current assets:
|
||||||||
Accrued expenses, non-tax deductible
|
$ | 5 | $ | 344 | ||||
Deferred revenue
|
556 | 645 | ||||||
Contingent payments
|
(831 | ) | (627 | ) | ||||
Noncurrent assets:
|
||||||||
Stock compensation expense
|
543 | 513 | ||||||
Loss carryforwards
|
71,122 | 79,811 | ||||||
Depreciation and amortization
|
1,929 | 2,486 | ||||||
73,324 | 83,172 | |||||||
Less: valuation allowance
|
(73,324 | ) | (83,172 | ) | ||||
$ | -- | $ | -- |
Number of Options
|
Option Price
Per Share
|
Weighted Average
Exercise Price
|
Aggregate Intrinsic Value | ||||||||||||
Balance at December 31, 2010
|
3,503,157 | 0.09-581.00 | $ | 0.60 | |||||||||||
Granted
|
880,000 | 0.06-0.10 | $ | 0.07 | |||||||||||
Forfeited
|
(85,000 | ) | 0.09-0.10 | $ | 0.10 | ||||||||||
Expired
|
(1,964 | ) | 174.00-581.00 | $ | 234.78 | ||||||||||
Balance at December 31, 2011
|
4,296,193 | 0.06-39.00 | $ | 0.39 | |||||||||||
Granted
|
70,000 | 0.05-0.19 | $ | 0.14 | |||||||||||
Forfeited
|
(440,000 | ) | 0.06-31.00 | $ | 0.35 | ||||||||||
Expired
|
(4,700 | ) | 34.00-39.00 | $ | 36.39 | ||||||||||
Balance at December 31, 2012
|
3,921,493 | 0.06-46.00 | $ | 0.36 |
$0.00
|
Number of Options
|
Option Price
Per Share
|
Weighted Average
Exercise Price
|
||||||||||
Balance at December 31, 2010
|
1,021,503 | 0.09 | $ | 0.09 | ||||||||
Granted
|
880,000 | 0.06-0.10 | $ | 0.07 | ||||||||
Vested
|
(945,756 | ) | 0.06-0.15 | $ | 0.08 | |||||||
Forfeited
|
(3,333 | ) | 0.09 | $ | 0.09 | |||||||
Balance at December 31, 2011
|
952,414 | 0.06-0.10 | $ | 0.08 | ||||||||
Granted
|
70,000 | 0.05-0.19 | $ | 0.14 | ||||||||
Vested
|
(805,747 | ) | 0.05-0.09 | $ | 0.08 | |||||||
Forfeited
|
(75,000 | ) | 0.08-0.09 | $ | 0.08 | |||||||
Balance at December 31, 2012
|
141,667 | 0.05-0.19 | $ | 0.10 |
Exercise Price
|
Number Outstanding
|
Remaining Contractual Life for Options Oustanding
|
Number
Exercisable
|
Weighted Average
Exercise Price |
||||||||||||||
$0.05-0.08 | 817,500 | 8.6 | 717,500 | $ | 0.07 | |||||||||||||
0.09 | 1,234,750 | 7.6 | 1,234,750 | 0.09 | ||||||||||||||
0.10-0.37 | 420,000 | 6.5 | 378,333 | 0.15 | ||||||||||||||
0.38-46.00 | 1,449,243 | 4.58 | 1,449,243 | 0.82 | ||||||||||||||
3,921,493 | 6.6 | 3,779,826 | $ | 0.37 |
Lease
Commitments
|
||||
2013
|
$ | 98 | ||
2014
|
59 | |||
$ | 157 |
1.
|
Employment
. The Company hereby employs Employee and Employee hereby accepts such employment upon the terms and conditions set forth in this Agreement.
|
2.
|
Duties of Employee
. Employee will be based in New Jersey or North Carolina at the discretion of the Company. Employee’s title will be Chief Executive Officer, Chief Financial Officer, Chief Operating Officer and Corporate Secretary and Employee will report directly to the Board of Directors of the Company. Employee agrees to perform and discharge such other duties as may be assigned to Employee from time to time by the Company to the reasonable satisfaction of the Board of Directors , and such duties will be consistent with those duties regularly and customarily assigned by the Company to the position of Chief Executive Officer, Chief Financial Officer and Secretary. Employee agrees to comply with all of the Company's policies, standards and regulations and to follow the instructions and directives as promulgated by the Board of Directors of the Company. Employee will devote Employee's full professional and business-related time, skills and best efforts to such duties and will not, during the term of this Agreement, be engaged (whether or not during normal business hours) in any other business or professional activity, whether or not such activity is pursued for gain, profit or other pecuniary advantage, without the prior written consent of the Board of Directors of the Company. This Section will not be construed to prevent Employee from (a) investing personal assets in businesses which do not compete with the Company in such form or manner that will not require any services on the part of Employee in the operation or the affairs of the companies in which such investments are made and in which Employee's participation is solely that of an investor; (b) purchasing securities in any corporation whose securities are listed on a national securities exchange or regularly traded in the over-the-counter market, provided that Employee at no time owns, directly or indirectly, in excess of one percent (1%) of the outstanding stock of any class of any such corporation engaged in a business competitive with that of the Company; or (c) participating in conferences, preparing and publishing papers or books, teaching or joining or participating in any professional associations or trade group, so long as the Board of Directors of the Company approves such participation, preparation and publication or teaching prior to Employee’s engaging therein.
|
3.
|
Term
. The term of this Agreement will be at-will, and can be terminated by either party at any time, with or without cause, subject to the provisions of Section 4 of this Agreement. Subject to the provisions of Section4, this Agreement will cover the period January 1, 2012 through December 31, 2012 and thereafter successive annual periods unless a party provides the other with written notice of its intention to terminate this Agreement, which notice shall be delivered no later than thirty (30) days prior to the expiration of the initial term or any renewal term, as applicable.
|
4.
|
Termination
.
|
|
(a)
|
Termination by Company for Cause
. The Company may terminate this Agreement and all of its obligations hereunder immediately, including the obligation to pay Employee severance, vacation pay or any further accrued benefits or remuneration, if any of the following events occur:
|
|
(i)
|
Employee improperly performs, or fails to perform, his duties and responsibilities or materially breaches any of the terms or conditions set forth in this Agreement, a Policy, or invention assignment, confidentiality, non-solicitation or non-competition agreement with or for the benefit of the Company, and fails to cure such breach within ten (10) days after Employee's receipt from the Company of written notice of such breach (notwithstanding the foregoing, no cure period shall be applicable to breaches by Employee of Sections 10 through 14 of this Agreement or of provisions of such Policies or agreements relating to any thereof);
|
|
(ii)
|
Employee commits any other act materially detrimental to the business or reputation of the Company;
|
|
(iii)
|
Employee engages in willful misconduct, including fraud or intentional misrepresentation;
|
|
(iv)
|
Employee engages in dishonest activities or commits or is convicted of, or pleads guilty or nolo contendere to, any felony or a misdemeanor involving fraud, deceit, moral turpitude or unethical business conduct;
|
|
(v)
|
Employee engages in habitual alcohol or drug abuse that continues after written notice from the Company, which abuse has (a) had an adverse effect on Employee’s productivity or ability to carry out his duties under this Agreement, (b) jeopardized the safety of any other employee of the Company or any person having business relations with the Company, (c) damaged the reputation of the Company, or (d) endangered the Company’s ability to compete for business; or
|
|
(vi)
|
Employee dies or becomes mentally or physically incapacitated or disabled so as to be unable to perform Employee's duties under this Agreement even with a reasonable accommodation. Without limiting the generality of the foregoing, Employee's inability adequately to perform services under this Agreement for a period of sixty (60) consecutive days will be conclusive evidence of such mental or physical incapacity or disability, unless such inability is pursuant to a mental or physical incapacity or disability covered by the Family Medical Leave Act, in which case such sixty (60) day period shall be extended to a one hundred and twenty (120) day period.
|
|
(b)
|
Termination by Company Without Cause
. The Company may terminate Employee's employment pursuant to this Agreement for reasons other than those stated in Section 4(a) upon at least thirty (30) days' prior written notice to Employee. In the event Employee's employment with the Company is terminated by the Company without cause, the Company shall be obligated to pay Employee a lump sum severance payment equal to twelve (12) months of Employee’s then base salary payable within thirty (30) days after the date of termination. In addition, Employee will be entitled to payment of all unused vacation days at his current daily rate and any accrued but unpaid salary or earned bonuses. Any option grants or restricted stock awards made to employee will immediately vest. The payment to Employee for all deferred salaries and earned bonuses will be paid within 30 days by the Company. Other than the severance payments set forth in this Section 4(b), Employee will be entitled to receive no further remuneration and will not be entitled to participate in any Company benefit programs following his termination by the Company, whether such termination is with or without cause.
|
|
(c)
|
Termination by Employee for Cause
. In the event of a Change of Control (as defined below) of the Company that results in either a substantial reduction or change of title in the Employee’s job duties related to his position as CFO or CEO, or a decrease in or a failure to provide the compensation or vested benefits under this Agreement or the Company initiates a substantial reduction or change of title in the Employee’s job duties related to his position as CFO, Employee shall have the right to resign his employment and will be entitled to a lump sum severance payment equal to twelve (12) months of Employee’s then base salary payable within thirty (30) days after the date of termination In addition, Employee will be entitled to payment of all unused vacation days at his current daily rate and a lump sum equal to all deferred salaries and earned bonuses. In addition, all Employee’s then outstanding but unvested stock options shall vest one hundred percent (100%). Employee shall have 12 months from the date written notice is given to Employee about the announcement and closing of a transaction resulting in a Change in Control of the Company that would result in a substantial change in the Employee’s job duties or decrease his compensation or vested benefits under this Agreement to resign or this Section 4(c) shall not apply. In the event Employee resigns from the Company for any other reason, Employee will not be entitled to receive or accrue any further Company benefits or other remuneration under this Agreement, and Employee specifically agrees that he will not be entitled to receive any severance pay.
For purposes of this Section 4, a Change in Control shall be deemed to have occurred if any of the following occur:
|
|
(i)
|
the merger or consolidation of the Company with or into another unaffiliated entity, or the merger of another unaffiliated entity into the Company or another subsidiary thereof with the effect that immediately after such transaction the stockholders of the Company immediately prior to such transaction hold less than fifty percent (50%) of the total voting power of all securities generally entitled to vote in the election of directors, managers or trustees of the entity surviving such merger or consolidation. This provision will not apply to any reorganization and reverse merger between the Company and any subsidiary (or any other similar entity established for a similar purpose);
|
|
(ii)
|
the sale or transfer of more than fifty-one percent (51%) of the Company’s then outstanding voting stock (other than a restructuring event which results in the continuation of the Company’s business by an affiliated entity) to unaffiliated person or group (as such term is used in Section 13(d)(3) of the Securities Exchange Act of 1934, as amended); or
|
|
(iii)
|
the adoption by the stockholders of the Company of a plan relating to the liquidation or dissolution of the Company.
|
|
(a)
|
Annual Salary
. During the term of this Agreement and for all services rendered by Employee under this Agreement, the Company will pay Employee a base salary of One Hundred and Seventy-Five Thousand Dollars ($175,000.00) per annum in equal bi-monthly installments. Employee will also be entitled to earn a short term incentive compensation as further outlined in Exhibit D.
|
|
(b)
|
Incentive Compensation
. Employee is eligible for an annual bonus upon the Company reaching certain pre tax income levels (after accounting for all bonuses) as set forth in Exhibit C. Said bonus will be payable after the annual accounts have been presented to the Compensation Committee. Exhibit C attached hereto provides the benchmarks associated with achieving the Incentive Compensation.
|
|
(c)
|
Equity Awards
. Employee is eligible for stock option grants and restricted stock awards as determined by the Compensation Committee, including but not limited to the issuance of 1,500,000 shares of common stock of the Company in the event of termination, with or without cause, or in the event of a Change of Control (Ownership) of the Company.
|
6.
|
Vacation.
Employee shall be eligible for four (4) weeks of paid vacation annually, provided that such vacation is scheduled at such times that do not interfere with the Company’s legitimate business needs.
|
7.
|
Other Benefits
. Employee will be entitled to such fringe benefits as may be provided from time-to-time by the Company to its employees, including, but not limited to, group health insurance, life and disability insurance, and any other fringe benefits now or hereafter provided by the Company to its employees, if and when Employee meets the eligibility requirements for any such benefit. The Company reserves the right to change or discontinue any employee benefit plans or programs now being offered to its employees; provided, however, that all benefits provided for employees of the same position and status as Employee will be provided to Employee on an equal basis.
|
8.
|
Business Expenses
. Employee will be reimbursed for all reasonable expenses incurred in the discharge of Employee's duties under this Agreement pursuant to the Company's standard reimbursement policies.
|
9.
|
Withholding
. The Company will deduct and withhold from the payments made to Employee under this Agreement, state and federal income taxes, FICA and other amounts normally withheld from compensation due employees.
|
10.
|
Non-Disclosure of Proprietary Information
. Employee recognizes and acknowledges that the Trade Secrets (as defined below) and Confidential Information (as defined below) of the Company and its affiliates and all physical embodiments thereof (as they may exist from time-to-time, collectively, the “Proprietary Information”) are valuable, special and unique assets of the Company's and its affiliates' businesses. Employee further acknowledges that access to such Proprietary Information is essential to the performance of Employee's duties under this Agreement. Therefore, in order to obtain access to such Proprietary Information, Employee agrees that, except with respect to those duties assigned to him by the Company, Employee will hold in confidence all Proprietary Information and will not reproduce, use, distribute, disclose, publish or otherwise disseminate any Proprietary Information, in whole or in part, and will take no action causing, or fail to take any action necessary to prevent causing, any Proprietary Information to lose its character as Proprietary Information, nor will Employee make use of any such information for Employee's own purposes or for the benefit of any person, firm, corporation, association or other entity (except the Company) under any circumstances.
|
11.
|
Non-Solicitation Covenants
. Employee agrees that during Employee's employment by the Company and for a period of two (2) year following the termination of Employee's employment for whatever reason, Employee will not, directly or indirectly, on Employee's own behalf or in the service of or on behalf of any other individual or entity, divert, solicit or attempt to divert or solicit any individual or entity (i) who is a client of the Company at any time during the six (6)-month period prior to Employee's termination of employment with the Company (“Client”), or was actively sought by the Company as a prospective client, and (ii) with whom Employee had material contact while employed by the Company to provide similar services or products as such provided by Employee for the Company to such Clients or prospects. Employee further agrees and represents that during Employee's employment by the Company and for a period of two (2) year following any termination of Employee's employment for whatever reason, Employee will not, directly or indirectly, on Employee's own behalf or in the service of, or on behalf of any other individual or entity, divert, solicit or hire away, or attempt to divert, solicit or hire away, to or for any individual or entity which is engaged in providing similar services or products to that provided by the Company, any person employed by the Company for whom Employee had supervisory responsibility or with whom Employee had material contact while employed by the Company, whether or not such employee is a full-time employee or temporary employee of the Company, whether or not such employee is employed pursuant to written agreement and whether or not such employee is employed for a determined period or at-will. For purposes of this Agreement, “material contact” exists between Employee and a Client or potential Client when (1) Employee established and/or nurtured the Client or potential Client; (2) the Client or potential Client and Employee interacted to further a business relationship or contract with the Company; (3) Employee had access to confidential information and/or marketing strategies or programs regarding the Client or potential Client; and/or (4) Employee learned of the Client or potential Client through the efforts of the Company providing Employee with confidential Client information, including but not limited to the Client’s identify, for purposes of furthering a business relationship.
|
12.
|
Existing Restrictive Covenants
. Except as provided in Exhibit B, Employee has not entered into any agreement with any employer or former employer: (a) to keep in confidence any confidential information, or (b) to not compete with any former employer. Employee represents and warrants that Employee's employment with the Company does not and will not breach any agreement which Employee has with any former employer to keep in confidence confidential information or not to compete with any such former employer. Employee will not disclose to the Company or use on its behalf any confidential information of any other party required to be kept confidential by Employee.
|
13.
|
Return of Proprietary Information
. Employee acknowledges that as a result of Employee's employment with the Company, Employee may come into the possession and control of Proprietary Information, such as proprietary documents, drawings, specifications, manuals, notes, computer programs, or other proprietary material. Employee acknowledges, warrants and agrees that Employee will return to the Company all such items and any copies or excerpts thereof, and any other properties, files or documents obtained as a result of Employee's employment with the Company, immediately upon the termination of Employee's employment with the Company.
|
14.
|
Proprietary Rights
. During the course of Employee's employment with the Company, Employee may make, develop or conceive of useful processes, machines, compositions of matter, computer software, algorithms, works of authorship expressing such algorithm, or any other discovery, idea, concept, document or improvement which relates to or is useful to the Company's Business (the “Inventions”), whether or not subject to copyright or patent protection, and which may or may not be considered Proprietary Information. Employee acknowledges that all such Inventions will be “works made for hire” under United States copyright law and will remain the sole and exclusive property of the Company. Employee also hereby assigns and agrees to assign to the Company, in perpetuity, all right, title and interest Employee may have in and to such Inventions, including without limitation, all copyrights, and the right to apply for any form of patent, utility model, industrial design or similar proprietary right recognized by any state, country or jurisdiction. Employee further agrees, at the Company's request and expense, to do all things and sign all documents or instruments necessary, in the opinion of the Company, to eliminate any ambiguity as to the ownership of, and rights of the Company to, such Inventions, including filing copyright and patent registrations and defending and enforcing in litigation or otherwise all such rights.
|
15.
|
Remedies
. Employee agrees and acknowledges that the violation of any of the covenants or agreements contained in Sections 10 through 14 of this Agreement would cause irreparable injury to the Company, that the remedy at law for any such violation or threatened violation thereof would be inadequate, and that the Company will be entitled, in addition to any other remedy, to temporary and permanent injunctive or other equitable relief without the necessity of proving actual damages or posting a bond.
|
16.
|
Severability
. In case one or more of the provisions contained in this Agreement is for any reason held to be invalid, illegal or unenforceable in any respect, the parties agree that it is their intent that the same will not affect any other provision in this Agreement, and this Agreement will be construed as if such invalid or illegal or unenforceable provision had never been contained herein. It is the intent of the parties that this Agreement be enforced to the maximum extent permitted by law.
|
17.
|
Entire Agreement
. This Agreement embodies the entire agreement of the parties relating to the subject matter of this Agreement and supersedes all prior agreements, oral or written, regarding the subject matter hereof. No amendment or modification of this Agreement will be valid or binding upon the parties unless made in writing and signed by the parties.
|
18.
|
Governing Law
. This Agreement is entered into and will be interpreted and enforced pursuant to the laws of the State of New Jersey. The parties hereto hereby agree that the appropriate forum and venue for any disputes between any of the parties hereto arising out of this Agreement shall be any federal court in the state where the Employee has his principal place of residence and each of the parties hereto hereby submits to the personal jurisdiction of any such court. The foregoing shall not limit the rights of any party to obtain execution of judgment in any other jurisdiction. The parties further agree, to the extent permitted by law, that a final and unappealable judgment against either of them in any action or proceeding contemplated above shall be conclusive and may be enforced in any other jurisdiction within or outside the United States by suit on the judgment, a certified exemplified copy of which shall be conclusive evidence of the fact and amount of such judgment.
|
19.
|
Surviving Terms
. Sections 4, 10, 11, 14, 15 and 18 of this Agreement shall survive termination of this Agreement.
|
COMPANY: | EMPLOYEE: | ||||
CICERO, INC. | |||||
By: |
/s/ Charles Porciello
|
/s/ John P. Broderick
|
|||
Name:
Charles Porciello
|
John P. Broderick | ||||
Title:
Board of Directors - Compensation Committee
|
Operating Net Income Range (before tax)
|
|||
From
|
To
|
Variable Compensation
|
|
Less than Target Operating Net Income
|
None
|
||
Tier 1
|
Achieve Target Operating Net Income up to 120% of Target
|
|
43% of 43% of base compensation
|
Tier 2
|
Achieve >120% of Target Net Operating Income ; < 150%
|
86% of base compensation
|
|
Tier 3
|
Achieve > 150% of Target Net
Operating Income
|
143% of base compensation
|
|
Performance significantly in excess of Tier 3 may result in an additional
reward at the discretion of the Compensation Committee
|
1.
|
I have reviewed this Annual Report on Form 10-K of Cicero Inc., |
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
|
a)
|
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
|
b)
|
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principals;
|
|
c)
|
evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based upon such evaluation; and
|
|
d)
|
disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
5.
|
I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
|
|
a)
|
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
|
b)
|
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
|
Date: April 15, 2013
|
By:
|
/s/ John P. Broderick | |
John P. Broderick | |||
Chief Executive Officer |
1. | I have reviewed this Annual Report on Form 10-K of Cicero Inc., |
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
|
a)
|
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
|
b)
|
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principals;
|
|
c)
|
evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based upon such evaluation; and
|
|
d)
|
disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
5.
|
I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
|
|
a)
|
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
|
b)
|
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
|
Date: April 15, 2013
|
By:
|
/s/ John P. Broderick | |
John P. Broderick
Chief Financial Officer
|
Date: April 15, 2013 | By: |
/s/ John P. Broderick
|
|
John P. Broderick
|
|||
Chief Executive and Financial Officer
|
|||
(Principal Financial and Accounting Officer)
|
|||